So in this video we are going to cover an important treatment for intermediate risk or Teal prostate cancer called High Dose Rate Temporary Seeds or “HDR.”  Seed implantation comes in two forms. You can look at our video on permanent seeds, which is the most popular type of…

Brachytherapy seeds will be the first in this series because in many ways in can be argued to be the best treatment or at least the best standard treatment for Teal.  Treatment for Teal involves a variety of comparisons…

In this video we’re going to cover a brief overview of the stage we call Teal.  Teal is a transition stage between harmless prostate cancer, which we call Sky, and consequential prostate cancer which we call Azure.  We break Teal into three sub-types: Low, Basic, and High. Low-Teal…

Hello Researcher, welcome to our fall issue of Prostate Digest. We recently held the 2018 Prostate Cancer Conference, and this issue has a summary of the event and information about how to get the event DVD. This issue contains four important articles covering new treatments and scans. The first highlights a recently FDA-approved oral medication called Earleada, which provided highly-effective therapy for men with hormone resistance. Our second articles reviews brachytherapy (seed implants) which are…

PCRI is grateful to everyone who attended our annual Prostate Cancer Conference, and we extend our thanks to all of the heroes who donate to ensure we can continue our mission. For those who were unable to attend, here is a recap of all of the wonderful information and events at the 2018 Prostate Cancer Conference. You can also order a DVD of the main sessions and Q+As at our website www.pcri.org

1. Always obtain and keep copies of your medical records.

2. Take things a step at a time and do your research. This is your life and your health, so you want to make the best decisions for yourself. Talk to your doctor about what you have researched, and don’t be afraid to do more research on treatments your doctor discusses with you.

In February 2018, the FDA approved Erleada for the treatment of prostate cancer. Erleada is an oral medicine approved for nonmetastatic, hormone-resistant disease. Men who have a rising PSA, low testosterone, and clear scans should begin Erleada immediately. Phase 3 SPARTAN clinical trial data showed that ERLEADA™ delays the  development of metastasis by over two years.

When your doctor gives you the results of your biopsy and tells you that you have cancer, many questions race through your mind. “Are you sure? How could I have cancer when I feel fine? Could this be a mistake?”

Over 160,000 men are diagnosed with prostate cancer in the United States each year. These men face the daunting task of choosing a treatment. Multiple options are available, but most men are not armed with the necessary information they need to make an informed decision. Both urologists and radiation oncologists offer several treatments and very often give patients conflicting information, further clouding the decision making process. Despite this, it is still critical that patients seek out physicians with…

In 2007, three years after the surgical removal of my prostate due to cancer, I joined the approximately 30 percent of men who are not cured by removing or radiating their prostates. Fourteen years after diagnosis, my slowly rising PSA is up to 0.4 ng/ml. I need to make the decision of whether or not to treat the cancer with radiation. If I continue waiting to do salvage radiation, perhaps my “window of curability” will close. For a discussion about radiation after prostatectomy see http://pcabefore50.blogspot.com/2010/06/nine-decisions.html